SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 25th, 2023 • Immatics N.V. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 25th, 2023 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of July 19, 2023 by and between Immatics N.V., a public limited liability company (naamloze vennootschap) under Dutch law (the “Company”), and Bristol-Myers Squibb Company (the “Investor”).